Livermore

Drugs Made In America Acquisition Corp.

DMAA
Exchange
Nasdaq
Industry
Blank Checks
SEC CIK
0002028614

Other share classesDMAARDMAAU

Insider trades, last 90 days

None

  • No open-market purchases or sales were filed in the last 90 days.
View insider trades

13F holders, Q2 2026

23

  • −16 vs. Q1 2026
  • Total value $145.78M
View 13F holders

Superinvestors holding DMAA

0

  • None of the superinvestors held DMAA at the end of Q2 2026.
See all holders

Price chart

Latest insider trades

View all: Latest insider trades

Open-market purchases and sales by DMAA insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Feb 18, 2025Feb 18, 2025Drugs Made In America Acquisition LLC10% OwnerPPurchaseOrdinary shares+30K––4.19M+0.7%SEC
Feb 18, 2025Feb 18, 2025Drugs Made In America Acquisition LLC10% OwnerPPurchaseOrdinary shares · Derivative+30K––430K–SEC
Feb 18, 2025Feb 18, 2025Stockwell LynnCEO and Exe. Chair of BoardPPurchaseOrdinary shares+30K––4.19M+0.7%SEC
Feb 18, 2025Feb 18, 2025Stockwell LynnCEO and Exe. Chair of BoardPPurchaseOrdinary shares · Derivative+30K––430K–SEC
Feb 4, 2025Jan 29, 2025Drugs Made In America Acquisition LLC10% OwnerPPurchaseOrdinary shares+400K––10.26M+4.1%SEC

Top 5 13F holders, Q2 2026

View all: Top 5 13F holders, Q2 2026

The largest institutional positions in DMAA at the end of Q2 2026.

Institutions holding DMAA in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
MIZUHO SECURITIES USA LLC4,069,605$42.83M0.41%+2,069,605+103.5%Added
Karpus Management, Inc.2,507,817$26.71M0.77%−22,700−0.9%Reduced
Polar Asset Management Partners Inc.1,146,000$12.2M0.22%−454,000−28.4%Reduced
GLAZER CAPITAL, LLC999,899$10.65M0.26%−678,507−40.4%Reduced
WOLVERINE ASSET MANAGEMENT LLC832,093$8.86M0.12%−721,615−46.4%Reduced